Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.
2.

Germline competency of human embryonic stem cells depends on eomesodermin.

Chen D, Liu W, Lukianchikov A, Hancock GV, Zimmerman J, Lowe MG, Kim R, Galic Z, Irie N, Surani MA, Jacobsen SE, Clark AT.

Biol Reprod. 2017 Jan 1;97(6):850-861. doi: 10.1093/biolre/iox138.

3.

Medial HOXA genes demarcate haematopoietic stem cell fate during human development.

Dou DR, Calvanese V, Sierra MI, Nguyen AT, Minasian A, Saarikoski P, Sasidharan R, Ramirez CM, Zack JA, Crooks GM, Galic Z, Mikkola HK.

Nat Cell Biol. 2016 Jun;18(6):595-606. doi: 10.1038/ncb3354. Epub 2016 May 16.

4.

Effects of dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], on cell viability and gene expression of common human cancer drug targets in a melanoma cell line.

Pojskic L, Haveric S, Lojo-Kadric N, Hadzic M, Haveric A, Galic Z, Galic B, Vullo D, Supuran CT, Milos M.

J Enzyme Inhib Med Chem. 2016 Dec;31(6):999-1004. doi: 10.3109/14756366.2015.1078329. Epub 2015 Aug 24.

PMID:
26307919
5.

Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs.

Menon T, Firth AL, Scripture-Adams DD, Galic Z, Qualls SJ, Gilmore WB, Ke E, Singer O, Anderson LS, Bornzin AR, Alexander IE, Zack JA, Verma IM.

Cell Stem Cell. 2015 Apr 2;16(4):367-72. doi: 10.1016/j.stem.2015.02.005. Epub 2015 Mar 12.

6.

In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium-trioxohydroxytetrafluorotriborate (K2[B3O3F4OH]).

Ivankovic S, Stojkovic R, Galic Z, Galic B, Ostojic J, Marasovic M, Milos M.

J Enzyme Inhib Med Chem. 2015 Jun;30(3):354-9. doi: 10.3109/14756366.2014.926344. Epub 2014 Jun 18.

PMID:
24939106
7.

Social desirability scales as indicators of self-enhancement and impression management.

Parmač Kovačić M, Galić Z, Jerneić Ž.

J Pers Assess. 2014;96(5):532-43. doi: 10.1080/00223891.2014.916714. Epub 2014 May 16.

PMID:
24837586
8.

Antioxidant characterization of oak extracts combining spectrophotometric assays and chemometrics.

Popović BM, Stajner D, Zdero R, Orlović S, Galić Z.

ScientificWorldJournal. 2013 Dec 25;2013:134656. doi: 10.1155/2013/134656. eCollection 2013.

9.

Human developmental chondrogenesis as a basis for engineering chondrocytes from pluripotent stem cells.

Wu L, Bluguermann C, Kyupelyan L, Latour B, Gonzalez S, Shah S, Galic Z, Ge S, Zhu Y, Petrigliano FA, Nsair A, Miriuka SG, Li X, Lyons KM, Crooks GM, McAllister DR, Van Handel B, Adams JS, Evseenko D.

Stem Cell Reports. 2013 Dec 12;1(6):575-89. doi: 10.1016/j.stemcr.2013.10.012. eCollection 2013.

10.

A spatially and chemically defined platform for the uniform growth of human pluripotent stem cells.

Jonas SJ, Alva JA, Richardson W, Sherman SP, Galic Z, Pyle AD, Dunn B.

Mater Sci Eng C Mater Biol Appl. 2013 Jan 1;33(1):234-41. doi: 10.1016/j.msec.2012.08.035. Epub 2012 Sep 11.

11.

Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.

Vatakis DN, Koya RC, Nixon CC, Wei L, Kim SG, Avancena P, Bristol G, Baltimore D, Kohn DB, Ribas A, Radu CG, Galic Z, Zack JA.

Proc Natl Acad Sci U S A. 2011 Dec 20;108(51):E1408-16. doi: 10.1073/pnas.1115050108. Epub 2011 Nov 28.

12.

How socio-economic conditions influence forest policy development in Central and South-east Europe.

Vuletić D, Potočić N, Krajter S, Seletković I, Fürst C, Makeschin F, Galić Z, Lorz C, Matijašič D, Zupanič M, Simončič P, Vacik H.

Environ Manage. 2010 Dec;46(6):931-40. doi: 10.1007/s00267-010-9566-3. Epub 2010 Oct 7.

PMID:
21161527
13.

GIS-based probability assessment of natural hazards in forested landscapes of Central and South-Eastern Europe.

Lorz C, Fürst C, Galic Z, Matijasic D, Podrazky V, Potocic N, Simoncic P, Strauch M, Vacik H, Makeschin F.

Environ Manage. 2010 Dec;46(6):920-30. doi: 10.1007/s00267-010-9508-0. Epub 2010 Jun 10.

PMID:
20535611
14.

A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.

Shimizu S, Hong P, Arumugam B, Pokomo L, Boyer J, Koizumi N, Kittipongdaja P, Chen A, Bristol G, Galic Z, Zack JA, Yang O, Chen IS, Lee B, An DS.

Blood. 2010 Feb 25;115(8):1534-44. doi: 10.1182/blood-2009-04-215855. Epub 2009 Dec 17.

15.

Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice.

Kitchen SG, Bennett M, Galić Z, Kim J, Xu Q, Young A, Lieberman A, Joseph A, Goldstein H, Ng H, Yang O, Zack JA.

PLoS One. 2009 Dec 7;4(12):e8208. doi: 10.1371/journal.pone.0008208.

16.

Derivation of primordial germ cells from human embryonic and induced pluripotent stem cells is significantly improved by coculture with human fetal gonadal cells.

Park TS, Galic Z, Conway AE, Lindgren A, van Handel BJ, Magnusson M, Richter L, Teitell MA, Mikkola HK, Lowry WE, Plath K, Clark AT.

Stem Cells. 2009 Apr;27(4):783-95. doi: 10.1002/stem.13.

17.

A self-renewal program controls the expansion of genetically unstable cancer stem cells in pluripotent stem cell-derived tumors.

Conway AE, Lindgren A, Galic Z, Pyle AD, Wu H, Zack JA, Pelligrini M, Teitell MA, Clark AT.

Stem Cells. 2009 Jan;27(1):18-28. doi: 10.1634/stemcells.2008-0529.

18.

Macrophage differentiation from embryoid bodies derived from human embryonic stem cells.

Subramanian A, Guo B, Marsden MD, Galic Z, Kitchen S, Kacena A, Brown HJ, Cheng G, Zack JA.

J Stem Cells. 2009;4(1):29-45. doi: jsc.2009.4.1.29.

19.

A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors.

Miranda-Carboni GA, Krum SA, Yee K, Nava M, Deng QE, Pervin S, Collado-Hidalgo A, Galic Z, Zack JA, Nakayama K, Nakayama KI, Lane TF.

Genes Dev. 2008 Nov 15;22(22):3121-34. doi: 10.1101/gad.1692808.

20.

Generation of T lineage cells from human embryonic stem cells in a feeder free system.

Galić Z, Kitchen SG, Subramanian A, Bristol G, Marsden MD, Balamurugan A, Kacena A, Yang O, Zack JA.

Stem Cells. 2009 Jan;27(1):100-7. doi: 10.1634/stemcells.2008-0813.

21.

T lineage differentiation from human embryonic stem cells.

Galic Z, Kitchen SG, Kacena A, Subramanian A, Burke B, Cortado R, Zack JA.

Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11742-7. Epub 2006 Jul 14.

22.

beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA.

Chang M, Brown HJ, Collado-Hidalgo A, Arevalo JM, Galic Z, Symensma TL, Tanaka L, Deng H, Zack JA, Sun R, Cole SW.

J Virol. 2005 Nov;79(21):13538-47.

23.

The CD4 molecule on CD8+ T lymphocytes directly enhances the immune response to viral and cellular antigens.

Kitchen SG, Whitmire JK, Jones NR, Galic Z, Kitchen CM, Ahmed R, Zack JA.

Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3794-9. Epub 2005 Feb 24.

24.

Expression-based monitoring of transcription factor activity: the TELiS database.

Cole SW, Yan W, Galic Z, Arevalo J, Zack JA.

Bioinformatics. 2005 Mar;21(6):803-10. Epub 2004 Sep 16.

PMID:
15374858
25.

CD4 on CD8(+) T cells directly enhances effector function and is a target for HIV infection.

Kitchen SG, Jones NR, LaForge S, Whitmire JK, Vu BA, Galic Z, Brooks DG, Brown SJ, Kitchen CM, Zack JA.

Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8727-32. Epub 2004 Jun 1.

26.

Controlling false-negative errors in microarray differential expression analysis: a PRIM approach.

Cole SW, Galic Z, Zack JA.

Bioinformatics. 2003 Sep 22;19(14):1808-16.

PMID:
14512352
27.

Combinatorial regulation of the murine RAG-2 promoter by Sp1 and distinct lymphocyte-specific transcription factors.

Miranda GA, Villalvazo M, Galic Z, Alva J, Abrines R, Yates Y, Evans CJ, Aguilera RJ.

Mol Immunol. 2002 Jun;38(15):1151-9.

PMID:
12044781
28.

Characterization of a novel DNA binding domain within the amino-terminal region of the RAG-1 protein.

Galic Z, Alva JA, Lin A, Lyon CJ, Aguilera RJ.

Biochem Mol Biol Int. 1998 Jul;45(3):535-44.

PMID:
9679654
29.

Regulation of the RAG-1 promoter by the NF-Y transcription factor.

Brown ST, Miranda GA, Galic Z, Hartman IZ, Lyon CJ, Aguilera RJ.

J Immunol. 1997 Jun 1;158(11):5071-4.

PMID:
9164918

Supplemental Content

Support Center